Aidin key facts
as of Oct 2026- Developer of a patient post-acute care management platform designed to defragment the healthcare ecosystem by connecting providers and patients.
- Aidin is valued at approximately $42.0M as of Oct 2026 (last reported valuation).
- It has raised $8.7M; the latest was Later Stage VC ($3.5M) in Aug 2025.
- Notable investors include Techstars, General Catalyst, Charles Songhurst, Red Swan Ventures, Romulus Capital — 21 tracked in total.
- Status: Privately Held (backing).
Aidin's last reported valuation, Aug 2025. Nothing priced has surfaced since.
- ·The complete investor list: 21 names
- ·Watch Aidin: the Monday email on marks, rounds and moves
Aidin funding rounds
No funding rounds for Aidin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Aidin
21+Aidin valuation
Aidin's last reported valuation was $42 million in Aug 2025. No priced round, secondary trade or fund mark has surfaced since.
Aidin investors
21 investors are on record for Aidin, including Techstars, General Catalyst, Charles Songhurst and Red Swan Ventures.
About Aidin
Developer of a patient post-acute care management platform designed to defragment the healthcare ecosystem by connecting providers and patients. The company's platform aids patients in making the right choice post-hospital by providing them with up-to-date ratings and reviews of the available providers in their area and giving them data on the outcomes of each provider's patients, enabling hospital social workers and case managers to discharge patients, decrease readmissions, and improve satisfaction.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2011
- Employees
- 45
- Website
- myaidin.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.